29645-00-9

Basic information

• Product Name: 2-(4-Chlorophenyl)butanoic acid
• Synonyms: 2-(4-Chlorophenyl)butanoic acid;2-(p-Chlorophenyl)butyric acid;Benzeneacetic acid,4-chloro-a-ethyl-
• CAS NO: 29645-00-9
• Molecular Formula: C₁₀H₁₁ClO₂
• Molecular Weight: 198.6461
• Mol File: 29645-00-9.mol
• Article Data: 10

Chemical Properties

• Melting Point: 83-85 °C
• Boiling Point: 311.3°Cat760mmHg
• Flash Point: 142.1°C
• Appearance: /
• Density: 1.221g/cm³
• Vapor Pressure: 0.000244mmHg at 25°C
• Refractive Index: 1.546
• PKA: 4.21±0.10(Predicted)
• CAS DataBase Reference: 2-(4-Chlorophenyl)butanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-Chlorophenyl)butanoic acid(29645-00-9)
• EPA Substance Registry System: 2-(4-Chlorophenyl)butanoic acid(29645-00-9)

Safety Data

• Hazardous Substances Data: 29645-00-9(Hazardous Substances Data)

Usage

Type of drug

Non-steroidal anti-inflammatory drug (NSAID)

Purpose

Relieves pain, inflammation, and fever

Mechanism of action

Inhibits the production of prostaglandins

Common uses

Treats arthritis, menstrual cramps, and minor injuries

Tolerance

Generally well-tolerated

Side effects

Can cause stomach upset and other gastrointestinal issues

Precautions

Should be used with caution in individuals with stomach ulcers, kidney problems, or heart disease, and under the guidance of a healthcare professional.

InChI:InChI=1/C10H11ClO2/c1-2-9(10(12)13)7-3-5-8(11)6-4-7/h3-6,9H,2H2,1H3,(H,12,13)

Upstream product

• 108-75-8 2,4,6-trimethyl-pyridine 
• 98947-23-0 1-(4-chloro-phenyl)-2-diazo-butan-1-one 
• 100-51-6 benzyl alcohol 
• 3984-34-7 4-(4-chlorophenyl)-4-oxobutanoic acid 
• 1878-66-6 4-chlorophenylacetic Acid 
• 74-96-4 ethyl bromide 
• 75-03-6 ethyl iodide 
• 7463-53-8 2RS-(4-nitrophenyl)butanoic acid 
• 29644-97-1 2-(4-aminophenyl)butanoic acid 
• 1745-18-2 1-allyl-4-chlorobenzene 

Downstream Products

• 51631-64-2 2-(4-chlorophenyl)butanoyl chloride 
• 1392494-07-3 2-(4-chlorophenyl)-N-(2-(pyrrolidin-1-yl)phenyl)butanamide 

Relevant articles and documents

Photoinduced Copper-Catalyzed Asymmetric Decarboxylative Alkynylation with Terminal Alkynes

We describe a photoinduced copper-catalyzed asymmetric radical decarboxylative alkynylation of bench-stable N-hydroxyphthalimide(NHP)-type esters of racemic alkyl carboxylic acids with terminal alkynes, which provides a flexible platform for the construction of chiral C(sp3)?C(sp) bonds. Critical to the success of this process are not only the use of the copper catalyst as a dual photo- and cross-coupling catalyst but also tuning of the NHP-type esters to inhibit the facile homodimerization of the alkyl radical and terminal alkyne, respectively. Owing to the use of stable and easily available NHP-type esters, the reaction features a broader substrate scope compared with reactions using the alkyl halide counterparts, covering (hetero)benzyl-, allyl-, and aminocarbonyl-substituted carboxylic acid derivatives, and (hetero)aryl and alkyl as well as silyl alkynes, thus providing a vital complementary approach to the previously reported method.

Novel compounds that reverse the disease phenotype in Type 2 Gaucher disease patient-derived cells

Gaucher disease (GD) results from inherited mutations in the lysosomal enzyme β-glucocerobrosidase (GCase). Currently available treatment options for Type 1 GD are not efficacious for treating neuronopathic Type 2 and 3 GD due to their inability to cross the blood-brain barrier. In an effort to identify small molecules which could be optimized for CNS penetration we identified tamoxifen from a high throughput phenotypic screen on Type 2 GD patient-derived fibroblasts which reversed the disease phenotype. Structure activity studies around this scaffold led to novel molecules that displayed improved potency, efficacy and reduced estrogenic/antiestrogenic activity compared to the original hits. Here we present the design, synthesis and structure activity relationships that led to the lead molecule Compound 31.

PYRETHROID COMPOUND, AND HAIR RESTORER AND HAIR RESTORER COMPOSITION COMPRISING THE SAME

PROBLEM TO BE SOLVED: To provide a pyrethroid compound having hair growth effect. SOLUTION: The present invention provides a pyrethroid compound represented by general formula (1) [in general formula (1), R1 is selected from a hydrogen atom, a halogen atom, an azido group, an alkoxy group having 1 to 4 carbon atoms, and an alkyl group having 1 to 4 carbon atoms, R2 is selected from a methyl group, an ethyl group and an isopropyl group, R3 is selected from -C≡N, -C≡CH, -C≡C-CH3 and -CH=CH2, and R4 is selected from a methyl group, a phenyl group, a 2-methoxy ethyl group, a methoxymethyl group, and a propargyl group]. SELECTED DRAWING: None COPYRIGHT: (C)2017,JPOandINPIT